VTGN VistaGen Therapeutics Inc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by VistaGen Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation of VistaGen Therapeutics, Inc. (NASDAQ: VTGN) concerning possible breaches of fiduciary duty. To obtain additional information, go to:

http://www.zlkdocs.com/VTGN-Info-Request-Form-6115

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
25/09/2017

Underlying

VTGNVistaGen Therapeutics Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on VistaGen Therapeutics Inc

 PRESS RELEASE
Free
VTGN VistaGen Therap...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Co...

NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of VistaGen Therapeutics, Inc. (NASDAQ: VTGN) concerning possible breaches of fiduciary duty. To obtain additional information, go to: http://www.zlkdocs.com/VTGN-Info-Request-Form-6115 or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you. Levi & Korsinsky is a national firm with offices in New York,...

September 25, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch